Clinical and pharmacological group: & nbsp

Oxazolidinones

Included in the formulation
  • Sivekstro
    lyophilizate d / infusion 
    Bayer Pharma AG     Germany
  • Sivekstro
    pills inwards 
    Bayer Pharma AG     Germany
  • АТХ:

    J.01.X.X.11   Tedisolide

    Pharmacodynamics:

    Synthetic antibacterial agent. It disrupts the synthesis of microbial proteins at the level of the ribosomes, by binding to 50Sthe subunit of bacterial ribosomes, inhibits the process of translocation. It penetrates into cells and creates a high intracellular concentration.

    Has a high activity against gram-positive cocci (staphylococci, streptococci).

    Pharmacokinetics:

    After oral administration, up to 91% is absorbed in the gastrointestinal tract. The maximum concentration in the blood plasma is reached after 15 minutes, with intravenous administration - after 1 minute. The connection with plasma proteins is 89%.

    Therapeutic effect develops after the reception. Metabolism in the liver.

    The elimination half-life is 10.6 hours. Elimination with feces and kidneys.

    Indications:

    It is used to treat infections of the skin and soft tissues.

    XII.L00-L08.L08.8   Other specified local infections of skin and subcutaneous tissue

    I.B00-B09.B08.8   Other specified infections characterized by skin and mucous membrane damage

    XII.L00-L08.L08.9   Local infection of skin and subcutaneous tissue, unspecified

    Contraindications:

    Age under 18, pregnancy and lactation,individual intolerance.

    Carefully:

    Renal and hepatic insufficiency, hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

    Dosing and Administration:

    Inside or intravenously slowly, 200 mg once a day for 6 days.

    The highest daily dose: 200 mg.

    The highest single dose: 200 mg.

    Side effects:

    Central and peripheral nervous system: headache, dizziness, peripheral neuropathy.

    Hemopoietic system: rarely - thrombocytopenia.

    Digestive system: nausea, candidiasis of the mucous membranes of the gastrointestinal tract, diarrhea.

    Sense organs: optic neuritis.

    Reproductive system: Candidiasis of the vagina.

    Allergic reactions.

    Overdose:

    Increased adverse reactions.

    Treatment is symptomatic. Effective hemodialysis.

    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    When using tidizolide in the form of a solution for infusions, mixing with other drugs is not recommended.

    Instructions
    Up